Clinical trials sponsored by Fujian Cancer Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Fujian Cancer Hospital

• Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
  NCT05019690 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
  NCT07467330 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 1 location
• Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer
  NCT07702708 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 5 locations

Common questions

How many trials is Fujian Cancer Hospital recruiting for?

Fujian Cancer Hospital is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.